Further studies combining different methodologies, such as transcriptomics, proteomics, and functional assays, will aid in thoroughly understanding the molecular and cellular mechanisms of USP30-AS1 in tumor-immune crosstalk and TME modulation. Here, USP30 is linked to neoplasm.